1. Home
  2. EYPT vs CLOV Comparison

EYPT vs CLOV Comparison

Compare EYPT & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EyePoint Pharmaceuticals Inc.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$16.10

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Clover Health Investments Corp.

CLOV

Clover Health Investments Corp.

HOLD

Current Price

$2.72

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYPT
CLOV
Founded
1987
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
EYPT
CLOV
Price
$16.10
$2.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$29.60
$4.23
AVG Volume (30 Days)
1.1M
4.6M
Earning Date
11-05-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$42,339,000.00
$1,773,564,000.00
Revenue This Year
N/A
$41.68
Revenue Next Year
N/A
$37.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.15
52 Week Low
$3.91
$2.12
52 Week High
$19.11
$4.87

Technical Indicators

Market Signals
Indicator
EYPT
CLOV
Relative Strength Index (RSI) 60.28 53.81
Support Level $15.97 $2.41
Resistance Level $19.11 $2.80
Average True Range (ATR) 0.96 0.10
MACD 0.11 0.05
Stochastic Oscillator 46.36 83.50

Price Performance

Historical Comparison
EYPT
CLOV

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About CLOV Clover Health Investments Corp.

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

Share on Social Networks: